Document text
Principal Investigator: PETER William RAMIREZ
Organization: CALIFORNIA STATE UNIVERSITY LONG BEACH
Fiscal Year: 2024
Award: $180,599
Funding agency: National Institute of Allergy and Infectious Diseases
Human Immunodeficiency Virus Type 1 (HIV-1) and Severe Acute Respiratory Syndrome Coronavirus Type 2
(SARS-CoV-2) are two enveloped RNA viruses that affect significant proportions of the global population. HIV-
1 and SARS-CoV-2 rely on lipid rafts to facilitate viral entry, assembly, and release, but the exact mechanisms
for how this occurs remain unclear. Lipid rafts represent distinct regions within cellular membranes that are
enriched in cholesterol, glycophospholipids, and protein receptors. Disrupting lipid-raft formation
pharmacologically reduces both HIV-1 and SARS-CoV-2 infection. Our long-term goal is to determine how
viruses hijack cellular proteins to disarm host defenses and co-opt cellular pathways to promote infection. The
objective in this application is to determine how the lipid-raft scaffold protein AnnexinA2 facilitates HIV-1 and
SARS-CoV-2 assembly. Our preliminary data suggest that AnnexinA2 interacts with two distinct viral
membrane proteins: HIV-1 Nef and SARS-CoV-2 Spike. Our central hypothesis is that AnnexinA2 facilitates
the localization of Nef and Spike to lipid-raft compartments, thereby augmenting viral assembly and infectivity.
The rationale for this project is that identifying specific mechanisms by which HIV-1 and SARS-CoV-2 exploit
AnnexinA2 to enhance viral infection will open new aspects of viral biology and offer new therapeutic
strategies. We aim to test our hypothesis by pursuing two specific aims: 1) Identify how AnnexinA2 facilitates
HIV-1 infection; and 2) Determine how AnnexinA2 promotes SARS-CoV-2 replication. In Aim 1, we will validate
whether Nef directly binds to AnnexinA2, determine whether the Nef/AnnexinA2 interaction correlates with the
enhanced prevalence of HIV-1, map the molecular determinants required for interaction, and determine
whether AnnexinA2 enriches Nef in lipid-rafts at the cell surface. Additionally, we will knockout AnnexinA2 via
CRISPR/Cas9 in primary cells to determine whether Nef requires AnnexinA2 to enhance infectivity. For Aim 2,
we will produce SARS-CoV-2 Virus Like Particles (SC2-VLPs) in both the presence and absence of AnnexinA2
to determine its role in facilitating SARS-CoV-2 assembly. We will also validate the SARS-CoV-2
Spike/AnnexinA2 interaction and delineate whether AnnexinA2 recruits Spike to lipid rafts at the ER-Golgi
Intermediate Compartment (ERGIC). The proposed research is innovative and significant because it will
generate novel models of retrovirus and coronavirus biology, vertically advancing both fields and providing
novel avenues for further mechanistic and therapeutic investigation.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV S protein><2019-nCoV spike glycoprotein><2019-nCoV spike protein><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Affect><Anti-viral Therapy><Binding><Biology><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 S protein><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 infection><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 spike><COVID-19 spike glycoprotein><COVID-19 spike protein><COVID-19 virus><COVID-19 virus infection><COVID-19 years><COVID19 infection><COVID19 virus><CRISPR approach><CRISPR based approach><CRISPR method><CRISPR methodology><CRISPR technique><CRISPR technology><CRISPR tools><CRISPR-CAS-9><CRISPR-based method><CRISPR-based technique><CRISPR-based technology><CRISPR-based tool><CRISPR/CAS approach><CRISPR/Cas method><CRISPR/Cas technology><CRISPR/Cas9><CRISPR/Cas9 technology><Calcium Binding><Cas nuclease technology><Cell Body><Cell Function><Cell Membrane Lipid Rafts><Cell Physiology><Cell Process><Cell membrane><Cell surface><Cells><Cellular Function><Cellular Membrane><Cellular Physiology><Cellular Process><Cholesterol><Clustered Regularly Interspaced Short Palindromic Repeats approach><Clustered Regularly Interspaced Short Palindromic Repeats method><Clustered Regularly Interspaced Short Palindromic Repeats methodology><Clustered Regularly Interspaced Short Palindromic Repeats technique><Clustered Regularly Interspaced Short Palindromic Repeats technology><CoV-2><CoV2><Coronaviridae><Coronavirus><Cytoplasmic Membrane><Data><Development><Endoplasmic Reticulum><Ergastoplasm><Goals><Golgi><Golgi Apparatus><Golgi Complex><HIV><HIV-1><HIV-I><HIV1><Host Defense><Host Factor><Host Factor Protein><Human><Human Immunodeficiency Virus Type 1><Human Immunodeficiency Viruses><Human immunodeficiency virus 1><Infection><Integration Host Factors><Investigation><Knock-out><Knockout><Knowledge><LAV-HTLV-III><Left><Lipid Binding><Lymphadenopathy-Associated Virus><Maps><Mediating><Membrane><Membrane Microdomains><Modeling><Modern Man><Molecular><Molecular Interaction><Outcome><Pathogenesis><Pathway interactions><Persons><Plasma Membrane><Population><Prevalence><Process><Proteins><Public Health><RNA Viruses><Receptor Protein><Research><Retroviridae><Retroviruses><Role><SARS Virus><SARS corona virus><SARS corona virus 2><SARS coronavirus><SARS-Associated Coronavirus><SARS-CO-V2><SARS-COVID-2><SARS-CoV><SARS-CoV-1><SARS-CoV-2><SARS-CoV-2 S><SARS-CoV-2 S protein><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 infection><SARS-CoV-2 pandemic><SARS-CoV-2 spike><SARS-CoV-2 spike glycoprotein><SARS-CoV-2 spike protein><SARS-CoV2><SARS-CoV2 infection><SARS-Related Coronavirus><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Scaffolding Protein><Severe Acute Respiratory Coronavirus><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 S protein><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 spike glycoprotein><Severe acute respiratory syndrome coronavirus 2 spike protein><Severe acute respiratory syndrome related corona virus 2><Site><Sphingolipid Microdomains><Sphingolipid-Cholesterol Rafts><Sphingolipids><Subcellular Process><Testing><Therapeutic><Viral><Viral Diseases><Viral Gene Products><Viral Gene Proteins><Viral M Proteins><Viral Matrix Proteins><Viral Membrane Proteins><Viral Proteins><Virion><Virus><Virus Assembly><Virus Diseases><Virus Particle><Virus Replication><Virus-HIV><Virus-Retrovirus><Virus-like particle><Wuhan coronavirus><calcium bound><corona virus><coronavirus disease 2019 S protein><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 infection><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 spike glycoprotein><coronavirus disease 2019 spike protein><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 virus><developmental><experiment><experimental research><experimental study><experiments><hCoV19><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><innovate><innovation><innovative><knock-down><knockdown><lipid bound><lipid raft><membrane structure><nCoV2><new drug target><new druggable target><new pharmacotherapy target><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapeutic target><new therapy approaches><new therapy target><new treatment approach><new treatment strategy><novel><novel drug target><novel druggable target><novel pharmacotherapy target><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapeutic target><novel therapy approach><novel therapy target><pandemic concern><pandemic potential><pandemic risk><pandemic threat><pathogen><pathogenic virus><pathway><pharmacologic><plasmalemma><receptor><recruit><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome-CoV><social role><spike proteins on SARS-CoV-2><therapeutically effective><trafficking><viral assembly><viral infection><viral infectious disease treatment><viral multiplication><viral pathogen><viral replication><virus infection><virus multiplication><virus pathogen><virus protein><virus-induced disease><virus-like nanoparticles><viruslike particle>